Search
Lexington, Mass., August 24, 2021 – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, today announced that it has been awarded a 10-year sole source contract for its innovative digital radiography (DR) systems from the U.S. Navy and Defense Logistics Agency (DLA).
Under the contract, Fujifilm will outfit U.S. Naval Fleet vessels with the company’s leading edge clinical DR x-ray room systems, featuring next-generation detector technology along with a high quality compact floor mounted room with all of the latest features. The initial DR system delivery and installation is slated for a new U.S. Navy ship later this year.
“Fujifilm is honored to be awarded this significant contract from the U.S. Navy as it speaks to the confidence and level of trust government officials place in our technology and our Fujifilm staff,” said Lou Cavallaro, Director, Government Business Sales, FUJIFILM Medical Systems U.S.A., Inc. “This achievement reflects Fujifilm’s ongoing commitment to developing the highest quality, innovative digital radiography technology for every application.”
This Sole Source DR Standardization contract was awarded to Fujifilm after a rigorous two-year evaluation and comparison with numerous competitive DR technologies. The U.S. Navy and DLA performed a comprehensive assessment of each manufacturer’s system technology, functionality, adaptability, service support infrastructure and cybersecurity compliance.
Fujifilm was selected as the singular vendor that best met or exceeded the U.S. Navy’s exacting standards and demanding criteria.
This latest contract is one in a long line of contracts for both Fujifilm’s medical imaging solutions and enterprise imaging portfolio. The company has been granted by various branches of the U.S. Federal Government, including a 10-year DOD Digital Imaging Network-PACS (DIN-PACS) IV contract as well as a 10 year Joint DLA/VA Radiology and Imaging Systems Contract.
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit https://stage.healthcaresolutions-us.fujifilm.com/
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com